Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Jason Hatfield

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Journal of Medicinal Chemistry|January 5, 2008
Identification of human intestinal carboxylesterase as the primary enzyme for activation of a doxazolidine carbamate prodrugBenjamin L Barthel, Renee C Torres, Janice L Hyatt, et al.
Journal of Natural Products|January 5, 2013
Modulation of esterified drug metabolism by tanshinones from Salvia miltiorrhiza ("Danshen")M Jason Hatfield, Lyudmila G Tsurkan, Janice L Hyatt, et al.
Biochemical Pharmacology|September 14, 2010
Organ-specific carboxylesterase profiling identifies the small intestine and kidney as major contributors of activation of the anticancer prodrug CPT-11M Jason Hatfield, Lyudmila Tsurkan, Michael Garrett, et al.
Chemico-Biological Interactions|February 20, 2016
Carboxylesterases: General detoxifying enzymesM Jason Hatfield, Robyn A Umans, Janice L Hyatt, et al.
Bioorganic & Medicinal Chemistry|July 8, 2011
Requirements for mammalian carboxylesterase inhibition by substituted ethane-1,2-dionesElizabeth I Parkinson, M Jason Hatfield, Lyudmila Tsurkan, et al.
Molecular Cancer Therapeutics|July 5, 2006
Development of an etoposide prodrug for dual prodrug-enzyme antitumor therapyK Jin Yoon, Jianjun Qi, Joanna S Remack, et al.
Journal of Medicinal Chemistry|March 24, 2007
Selective inhibition of carboxylesterases by isatins, indole-2,3-dionesJanice L Hyatt, Teri Moak, M Jason Hatfield, et al.
Journal of Medicinal Chemistry|January 24, 2017
Selective Inhibitors of Human Liver Carboxylesterase Based on a β-Lapachone Scaffold: Novel Reagents for Reaction ProfilingM Jason Hatfield, Jingwen Chen, Ellie M Fratt, et al.
Journal of Medicinal Chemistry|October 19, 2007
Planarity and constraint of the carbonyl groups in 1,2-diones are determinants for selective inhibition of human carboxylesterase 1Janice L Hyatt, Randy M Wadkins, Lyudmila Tsurkan, et al.
Cell Reports|December 2, 2014
Targeting the DNA repair pathway in Ewing sarcomaElizabeth Stewart, Ross Goshorn, Cori Bradley, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Journal of Medicinal Chemistry|January 5, 2008
Identification of human intestinal carboxylesterase as the primary enzyme for activation of a doxazolidine carbamate prodrugBenjamin L Barthel, Renee C Torres, Janice L Hyatt, et al.
Journal of Natural Products|January 5, 2013
Modulation of esterified drug metabolism by tanshinones from Salvia miltiorrhiza ("Danshen")M Jason Hatfield, Lyudmila G Tsurkan, Janice L Hyatt, et al.
Biochemical Pharmacology|September 14, 2010
Organ-specific carboxylesterase profiling identifies the small intestine and kidney as major contributors of activation of the anticancer prodrug CPT-11M Jason Hatfield, Lyudmila Tsurkan, Michael Garrett, et al.
Chemico-Biological Interactions|February 20, 2016
Carboxylesterases: General detoxifying enzymesM Jason Hatfield, Robyn A Umans, Janice L Hyatt, et al.
Bioorganic & Medicinal Chemistry|July 8, 2011
Requirements for mammalian carboxylesterase inhibition by substituted ethane-1,2-dionesElizabeth I Parkinson, M Jason Hatfield, Lyudmila Tsurkan, et al.
Molecular Cancer Therapeutics|July 5, 2006
Development of an etoposide prodrug for dual prodrug-enzyme antitumor therapyK Jin Yoon, Jianjun Qi, Joanna S Remack, et al.
Journal of Medicinal Chemistry|March 24, 2007
Selective inhibition of carboxylesterases by isatins, indole-2,3-dionesJanice L Hyatt, Teri Moak, M Jason Hatfield, et al.
Journal of Medicinal Chemistry|January 24, 2017
Selective Inhibitors of Human Liver Carboxylesterase Based on a β-Lapachone Scaffold: Novel Reagents for Reaction ProfilingM Jason Hatfield, Jingwen Chen, Ellie M Fratt, et al.
Journal of Medicinal Chemistry|October 19, 2007
Planarity and constraint of the carbonyl groups in 1,2-diones are determinants for selective inhibition of human carboxylesterase 1Janice L Hyatt, Randy M Wadkins, Lyudmila Tsurkan, et al.
Cell Reports|December 2, 2014
Targeting the DNA repair pathway in Ewing sarcomaElizabeth Stewart, Ross Goshorn, Cori Bradley, et al.
Pageof 2